RxDoctor Payments Data

Tonya Fordham, DO

Family Medicine · Baxley, GANPI 1861462053

Payments from drug & device makers

$331in general payments, 2019–2025

Across 12 payments — averaging $27.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$150
  • Pfizer$45
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$33
  • Dexcom, Inc.$32
  • Supernus Pharmaceuticals, Inc.$24
  • AstraZeneca$13
  • plus $34 from 3 others

What the payments were for

  • Speaking & faculty fees$15045%
  • Food & beverage$18155%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$331 in reported general payments places this provider in the 40th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$94,140
Medicare patients
165
Services billed
1,706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$80,830
EliquisApixaban309$70,964
MounjaroTirzepatide50$55,027
ProcritEpoetin Alfa23$24,908
FarxigaDapagliflozin Propanediol21$19,001
TrulicityDulaglutide20$18,396
JanuviaSitagliptin Phosphate59$15,066
ShingrixVaricella-Zoster Ge/As01b/Pf70$14,695
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,180
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$12,988
Breo ElliptaFluticasone/Vilanterol29$11,632
ArexvyRsvpref3 Antigen/As01e/Pf34$10,033
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,448
NamzaricMemantine Hcl/Donepezil Hcl51$6,498
JardianceEmpagliflozin46$6,393

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$12$80,83078 claims
PfizerEliquis$45$70,964309 claims
GSKShingrix, Breo Ellipta, Arexvy, Anoro Ellipta, Incruse Ellipta$11$50,188164 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$13$35,86356 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Baxley

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →